Clinical Trial Update: Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports the Phase 1 results of liposomal doxorubicin given before mastectomy in women with invasive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2013-09-26